Gemfibrozil hepatotoxicity: A case report

International Journal of Clinical Pharmacy

Volumn 33, Issue 5, 2011, Pages 730-732

  Tordera, Patricia Domínguez ^a   Alabern, José Francisco Comellas ^a   Rivero, Félix Ronda ^a  

^a Hospital Asepeyo Sant Cugat del Vallés   (Spain)

Author keywords

Gemfibrozil; Hepatitis; Side effects; Toxicity

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; DIPYRONE; ENOXAPARIN; ESOMEPRAZOLE; GAMMA GLUTAMYLTRANSFERASE; GEMFIBROZIL; OMEPRAZOLE; VENLAFAXINE;

ACUTE HEPATITIS; ADULT; ARTICLE; CASE REPORT; CHOLELITHIASIS; DIFFERENTIAL DIAGNOSIS; DRUG WITHDRAWAL; ECHOGRAPHY; FEMALE; FEMUR FRACTURE; FRACTURE; HUMAN; HYPERTRIGLYCERIDEMIA; LIVER FUNCTION TEST; MALAISE; NAUSEA; PRIORITY JOURNAL; STOMACH ULCER; TALUS FRACTURE; THORAX INJURY; TOXIC HEPATITIS; TRAFFIC ACCIDENT;

DRUG-INDUCED LIVER INJURY; FEMALE; GEMFIBROZIL; HUMANS; LIVER FUNCTION TESTS; MIDDLE AGED;

EID: 83255185141     PISSN: 22107703     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-011-9550-x     Document Type: Article

References (8)

1. Bustamante Balen M, Plume Gimeno G, Bau González I, Berenguer Lapuerta J. Acute(d) hepatitis caused by gemfibrozil. Gastroenterol Hepatol. 1998;21(8):419-20.
2. De Diego Lorenzo A, Catalina V, Garcia Sánchez A, Escudero M, Cos E, Clemente G. Cholestatic hepatitis caused by gemfibrozil. Rev Esp Enferm Dig. 2001;93(9):606-14.
3. Johnston DE. Special considerations in interpreting liver function tests. Am Fam Physician. 1999;59:2223-32.
4. Zimmerman HJ. Drug-induced liver disease. Clin Liver Dis. 2000; 4(1):73-96. (Pubitemid 33041487)
5. Navarro VJ, Senior JR. Drug-related hepatotoxicity. N Engl J Med. 2006;354(7):731-9. (Pubitemid 43247143)
6. Dufour DR, Lott JA, Nolte NS, Gretch DR, Koff RS, Seeff LB. National Academy of Clinical Biochemistry. Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem. 2000;46(12):2050-68.
7. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-45. (Pubitemid 12149145)
8. C-Y Ho, Kuo T-H, Chen T-S, Tsay S-H, Chang F-Y, Lee S-D. Fenofibrate-induced acute cholestatic hepatitis. J Chin Med Assoc. 2004;67(5):245-7. (Pubitemid 39069706)